Supermax BhdSPMXF 51 Return-on-Tangible-Equity is -4.42% as of Mar. 2026. GuruFocus rates SPMXF with a GF Score™ of 51/100 and a GF Value™ of $0.37. The stock has 6 warning signs investors should review. Among 758 Medical Devices & Instruments companies, Supermax Bhd ranks worse than 65.04% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Supermax Bhd's annualized net income for the quarter that ended in Mar. 2026 was $-41.7 Mil. Supermax Bhd's average shareholder tangible equity for the quarter that ended in Mar. 2026 was $942.7 Mil. Therefore, Supermax Bhd's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was -4.42%.
The historical rank and industry rank for Supermax Bhd's Return-on-Tangible-Equity or its related term are showing as below:
SPMXF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -7.6 Med: 11.2 Max: 121.95
Current: -7.6
During the past 13 years, Supermax Bhd's highest Return-on-Tangible-Equity was 121.95%. The lowest was -7.60%. And the median was 11.20%.
SPMXF's Return-on-Tangible-Equity is ranked worse than 65.04% of 758
companies
in the Medical Devices & Instruments industry
Industry Median: 4.08
vs SPMXF: -7.60
Supermax Bhd (OTCPK:SPMXF) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Supermax Bhd Return-on-Tangible-Equity Related Terms
Supermax Bhd Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Supermax Bhd's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SPMXF vs ISRG, BDX, MDLN: Return-on-Tangible-Equity Comparison
For the Medical Instruments & Supplies subindustry, Supermax Bhd's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Supermax Bhd Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Supermax Bhd's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Supermax Bhd's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of -4.42% mean?
Supermax Bhd (SPMXF) has a Return-on-Tangible-Equity of -4.42% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Supermax Bhd and its competitors. According to the industry distribution chart, Supermax Bhd ranks #493 out of 758 companies in the Medical Devices & Instruments industry, placing it in the top 65%.
Is Supermax Bhd's Return-on-Tangible-Equity too high?
Supermax Bhd's current Return-on-Tangible-Equity is -4.42%. Based on the distribution chart, Supermax Bhd ranks #493 out of 758 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Supermax Bhd has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does Supermax Bhd's Return-on-Tangible-Equity compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Supermax Bhd ranks #493 out of 758 companies for Return-on-Tangible-Equity. This places Supermax Bhd in the lower half of its industry. The industry median Return-on-Tangible-Equity is 4.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.08, based on 758 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Supermax Bhd and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Supermax Bhd's current Return-on-Tangible-Equity is -4.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Supermax Bhd stock overvalued right now?
Supermax Bhd (SPMXF) has a current Return-on-Tangible-Equity of -4.42%. The stock's GF Value™ is $0.37, compared to a current price of $0.15 — trading 59.5% below its estimated fair value. The current Return-on-Tangible-Equity is -4.42%. Supermax Bhd's overall GF Score™ is 51/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Supermax Bhd (SPMXF), the current Return-on-Tangible-Equity is -4.42% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Supermax Bhd (SPMXF) Overvalued in 2026?
Based on GuruFocus' analysis, Supermax Bhd stock appears to be undervalued.
The current stock price of $0.15 is trading 59.5% below its estimated GF Value™ of $0.37.
Key valuation signals for SPMXF:
Return-on-Tangible-Equity: -4.42%
GF Value™: $0.37 vs. price of $0.15 (59.5% below fair value)
No single metric tells the full story. See the SPMXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Supermax Corp Bhd is an investment holding company. Along with its subsidiaries, the company operates as an international manufacturer, distributor, and marketer of high-quality medical gloves and contact lenses. It offers various types of latex gloves, which are exported to numerous countries. The company is organized into the following reportable operating segments: manufacturing of gloves, which generates the majority of revenue; investment holding; trading of gloves; and others. Geographically, it derives the majority of its revenue from Europe, with the remainder coming from Africa, Asia and Oceania, and North, Central, and South America.
51GF Score
Get the complete analysis for SPMXF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SPMXF has been successfully added to your 
